Evidence map›Paper›PMID 39969108›Full record

ArticleCancer medicine2025

Promoting Racial Justice in Cancer Clinical Trials: Community Engaged Solutions for Bridging Gaps.

Deana M Williams, Chaya M Pflugeisen, Khadijah Ameen, Toby K Chen, Sheree Cooks, Bernadette C Ray, Melissa Foster, De Phillips, Lizbeth Sanchez, Keywanna Hardiman and 2 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Cancer medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Deana M WilliamsMultiCare Health System Institute for Research & Innovation, Puyallup, Washington, USA.ORCID https://orcid.org/0000-0001-5649-1425
Chaya M PflugeisenMultiCare Health System Institute for Research & Innovation, Puyallup, Washington, USA.
Khadijah AmeenClinical Trials Advisory Group, Puyallup, Washington, USA.
Toby K ChenClinical Trials Advisory Group, Puyallup, Washington, USA.
Sheree CooksClinical Trials Advisory Group, Puyallup, Washington, USA.
Bernadette C RayClinical Trials Advisory Group, Puyallup, Washington, USA.
Melissa FosterClinical Trials Advisory Group, Puyallup, Washington, USA.
De PhillipsClinical Trials Advisory Group, Puyallup, Washington, USA.
Lizbeth SanchezClinical Trials Advisory Group, Puyallup, Washington, USA.
Keywanna HardimanClinical Trials Advisory Group, Puyallup, Washington, USA.
Cynthia SmithMultiCare Health System Institute for Research & Innovation, Puyallup, Washington, USA.
Jennifer SlimMultiCare Cancer Institute, Tacoma, Washington, USA.

Funding

Andy Hill CARE Fund FY23-IDCT-05
6 · The paper itself

Abstract

introductionRacially and ethnically diverse populations are disproportionately burdened with and more likely to die from cancer than White populations but remain persistently underrepresented in cancer clinical trials. Thus, the safety and efficacy assessments of novel therapies may not apply to all populations, and guidelines are developed using trials that inadequately reflect our population. This study aims to explore healthcare experiences, cancer clinical trial perceptions, and solutions for bridging gaps in cancer clinical trials among communities of color.

methodsWe held a series of five focus groups with 23 survivors and caregivers of color. These sessions explored perspectives around cancer care and research, clinical trials recruitment and messaging, and priorities around addressing the current insufficiency in representation in cancer research.

resultsOur focus group data was analyzed using an inductive thematic approach. Four themes were present including (1) high motivation to participate in cancer trials and desire for better outreach and education within communities of color; (2) examples of just care as a model for improving access to clinical trials; (3) manifestations of power and inequity in healthcare inhibiting opportunities for clinical trial participation; and (4) the need for trust-building at the healthcare, community, and interpersonal levels.

conclusionOur findings demonstrate that people of color strongly desire clinical trial options and discussions during cancer care, and trust-building is foundational to opening pathways to research participation. We offer concrete steps for increasing racial justice in cancer clinical trials that serve as a point of reflection and guidance for healthcare professionals, researchers, and clinical trials teams.

Indexed as

Clinical Trials as TopicHealthcare DisparitiesNeoplasmsSocial JusticeAdultAgedCancer SurvivorsCaregiversFemaleFocus GroupsHumansMaleMiddle AgedPatient Selectionclinical trialshealthcarehealth equityinclusiononcologyracial and ethnic diversityracial justice

Identifiers

PMID39969108
PMCPMC11837037

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.